Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 13, 2014 - Issue 6
Submit an article Journal homepage
874
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Does aspirin increase the risk of age-related macular degeneration?

Elaine W ChongUniversity of Melbourne, Royal Victorian Eye and Ear Hospital, Centre for Eye Research Australia (CERA), 32 Gisbourne Street, East Melbourne, Victoria 3002, Australia+61 3 9929 8968; +61 399298379; [email protected]
, MBBS MEpi PhD FRANZCO,
Robyn H GuymerUniversity of Melbourne, Royal Victorian Eye and Ear Hospital, Centre for Eye Research Australia (CERA), 32 Gisbourne Street, East Melbourne, Victoria 3002, Australia
, MBBS PhD FRANZCO &
Liubov D RobmanMonash University, Alfred Hospital, ASPREE Coordinating Centre, Department of Epidemiology & Preventive Medicine, 99 Commercial Road, Melbourne, Victoria 3004, Australia;University of Melbourne, Centre for Eye Research Australia (CERA), 32 Gisbourne Street, East Melbourne, Victoria 3002, Australia
, MBBS PhD
Pages 691-693 | Published online: 29 Apr 2014

Bibliography

  • Christen WG, Chew EY. Does long-term aspirin use increase the risk of neovascular age-related macular degeneration? Expert Opin Drug Saf 2014;13(4):421-9
  • Klein BE, Howard KP, Gangnon RE, et al. Long-term use of aspirin and age-related macular degeneration. JAMA 2012;308(23):2469-78
  • Liew G, Mitchell P, Wong TY, et al. The association of aspirin use with age-related macular degeneration. JAMA Intern Med 2013;173(4):258-64
  • Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324(7329):71-86
  • de Jong PT, Chakravarthy U, Rahu M, et al. Associations between aspirin use and aging macula disorder: the European Eye Study. Ophthalmology 2012;119(1):112-18
  • Cheung N, Tay WT, Cheung GC, et al. Is aspirin intake associated with early age-related macular degeneration? The Singapore Indian Eye Study. Br J Ophthalmol 2013;97(6):785-8
  • Christen WG, Glynn RJ, Chew EY, Buring JE. Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women. Ophthalmology 2009;116(12):2386-92
  • Christen WG, Glynn RJ, Ajani UA, et al. Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians. Arch Ophthalmol 2001;119(8):1143-9
  • Nelson MR, Reid CM, Ames DA, et al. Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study. Med J Aust 2008;189(2):105-9
  • ASPREE Investigator Group. Study design of ASPirin in reducing events in the elderly (ASPREE): a randomized, controlled trial. Contemp Clin Trials 2013;36(2):555-64

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.